MedinCell S.A. (EPA:MEDCL)

Revenue by Segment

Financials in millions EUR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Conducting Research and Development on Biodegradable Polymer-Based Processes	27.73M	11.95M	13.66M	8.34M	8.19M
Conducting Research and Development on Biodegradable Polymer-Based Processes Growth	132.12%	-12.52%	63.77%	1.86%	36.43%
Total	27.73M	11.95M	13.66M	8.34M	8.19M
Total Growth	132.12%	-12.52%	63.77%	1.86%	36.43%

Revenue by Geography

Financials in millions EUR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Israel	3.16M	-	4.34M
Israel Growth	-	-	223.67%
United States	1.98M	2.41M	2.54M
United States Growth	-18.04%	-4.91%	97.73%
Switzerland	2.18M	1.31M	-
Switzerland Growth	66.23%	-	-
Others	2.57M	-	1.31M
Others Growth	-	-	474.05%
Germany	-	368.10K	-
Total	9.89M	4.09M	8.19M
Total Growth	141.78%	-50.04%	187.03%

Source: S&P Global Market Intelligence.